NCT05600283

Brief Summary

The purpose of this study is to validate a patient self-sampling vaginal collection kit and laboratory testing for the detection of HPV (human papillomavirus) infection. Researchers will compare the laboratory results of self-collected vaginal swab samples to usual healthcare provider-collected cervical swab samples to determine the laboratory HPV testing accuracy of the self-collection swab.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
222

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Nov 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 26, 2022

Completed
5 days until next milestone

First Posted

Study publicly available on registry

October 31, 2022

Completed
16 days until next milestone

Study Start

First participant enrolled

November 16, 2022

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 4, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 4, 2024

Completed
1.3 years until next milestone

Results Posted

Study results publicly available

September 19, 2025

Completed
Last Updated

January 6, 2026

Status Verified

October 1, 2024

Enrollment Period

1.6 years

First QC Date

October 26, 2022

Results QC Date

August 6, 2025

Last Update Submit

December 15, 2025

Conditions

Keywords

Cervical Cancer Screening

Outcome Measures

Primary Outcomes (1)

  • Concordance of Patient-collected and Clinician-collected Samples to Detect HPV Infection

    Patient-collected vaginal swab HPV results compared with gold standard of clinician-collected cervical swab) to accurately detect HPV infection

    Baseline (sample was collected up to 21 days form the date of registration)

Secondary Outcomes (1)

  • Patient-reported Acceptability of Using the Evalyn Brush

    Baseline (sample was collected up to 21 days form the date of registration)

Study Arms (1)

Self-collected vaginal swab samples

EXPERIMENTAL

Subjects will self-collect a vaginal swab (Evalyn brush) and complete a scheduled standard of care clinician-collected cervical swab

Diagnostic Test: Swab kit (COBAS HPV 4800 Assay -Evalyn brush)Diagnostic Test: Clinician-collection of cervical sample for HPV testing

Interventions

Patient self-sampling swab kit to collect a vaginal sample for HPV testing

Self-collected vaginal swab samples

Speculum exam and collection of a cervical specimen using standard endocervical brush and spatula placed into ThinPrep medium for HPV testing (Evalyn brush)

Self-collected vaginal swab samples

Eligibility Criteria

Age25 Years - 65 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Appointment at Mayo Clinic Rochester in Gynecology Colposcopy Clinic or ICS (integrated community specialty) Colposcopy Clinic (will always include a speculum exam).
  • Appointment at Mayo Clinic Rochester in Gynecology Clinic for indication that will already include a speculum exam (e.g., cervical cancer screening or IUD insertion).

You may not qualify if:

  • Excluded if self-reported as currently menstruating, pregnant, or within 3 months following pregnancy.
  • Excluded if no cervix (history of total hysterectomy).
  • Excluded if moderate to heavy vaginal bleeding on the day of the visit.
  • Excluded if reason for visit in Gynecology Clinic is abnormal vaginal discharge.
  • Exclude patients who are on Gynecology Colposcopy Clinic for LEEP (loop electrosurgical excision procedure).
  • Exclude if any use of over-the-counter or prescription vaginal cream for vaginal infection or prescription vaginal estrogen cream for at least two days before using the Evalyn Brush.
  • (Vaginal contraceptives, condoms and water-based lubricants can be used as normal.)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mayo Clinic Minnesota

Rochester, Minnesota, 55905, United States

Location

Related Links

Results Point of Contact

Title
Dr. Kathy MacLaughlin
Organization
Mayo Clinic

Study Officials

  • Kathy MacLaughlin, MD

    Mayo Clinic

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SCREENING
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 26, 2022

First Posted

October 31, 2022

Study Start

November 16, 2022

Primary Completion

June 4, 2024

Study Completion

June 4, 2024

Last Updated

January 6, 2026

Results First Posted

September 19, 2025

Record last verified: 2024-10

Data Sharing

IPD Sharing
Will not share

Locations